Market Place
Sourcing Support
Shattuck Labs to Attend December Conferences
25 Nov 2024 //
GLOBENEWSWIRE
Shattuck Labs Reports Q3 2024 Results & Highlights
14 Nov 2024 //
GLOBENEWSWIRE
Shattuck Labs Updates on SL-325, a DR3 Antagonist
01 Oct 2024 //
GLOBENEWSWIRE
Shattuck Labs Reports Q2 2024 Results And Business Highlights
01 Aug 2024 //
GLOBENEWSWIRE
Shattuck Labs To Participate In BTIG Virtual Biotechnology Conference
30 Jul 2024 //
GLOBENEWSWIRE
Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
01 Jul 2024 //
GLOBENEWSWIRE
Shattuck Reports Positive SL-172154 Data In HR-MDS And TP53m AML
14 Jun 2024 //
GLOBENEWSWIRE
Shattuck Gets FDA Orphan Drug Status For AML Drug SL-172154
10 Jun 2024 //
GLOBENEWSWIRE
Shattuck Labs To Host Investor Call And Webcast On Additional Interim Data
06 Jun 2024 //
GLOBENEWSWIRE
Shattuck Labs To Present SL-172154 + AZA Data In MDS/AML At EHA 2024
14 May 2024 //
GLOBENEWSWIRE
Shattuck Q1 2024 Results, Business Highlights
02 May 2024 //
GLOBENEWSWIRE
Shattuck Labs Presents Data at AACR 2024
09 Apr 2024 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming Virtual Healthcare Conference
01 Apr 2024 //
GLOBENEWSWIRE
Shattuck Labs Announces Appointment of Clay Siegall to its Board of Directors
04 Mar 2024 //
GLOBENEWSWIRE
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming March Conferences
26 Feb 2024 //
GLOBENEWSWIRE
Ono Enters into a Drug Discovery Collaboration with Shattuck Labs
14 Feb 2024 //
PR NEWSWIRE
Shattuck Enters into Strategic Collaboration and License Agreement with Ono
13 Feb 2024 //
GLOBENEWSWIRE
Shattuck Labs Highlights Upcoming Key Milestones in 2024
08 Jan 2024 //
GLOBENEWSWIRE
Shattuck Announces Presentation at Upcoming 42nd Annual J.P. Morgan Conference
04 Jan 2024 //
GLOBENEWSWIRE
Shattuck Labs Announces $50 Million Public Offering of Common Stock
21 Dec 2023 //
GLOBENEWSWIRE
Shattuck Labs Announces Positive Data from Ongoing Phase 1 Trial of SL-172154
13 Dec 2023 //
GLOBENEWSWIRE
Shattuck Labs to Host Investor Call and Webcast
05 Dec 2023 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming 6th Annual Conference
14 Nov 2023 //
GLOBENEWSWIRE
Shattuck Labs Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
06 Nov 2023 //
GLOBENEWSWIRE
Shattuck Labs to Present Data from Phase 1 A/B Clinical Trial of SL-172154
02 Nov 2023 //
GLOBENEWSWIRE
Shattuck Labs Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Shattuck to Present Complete Phase 1A Monotherapy Clinical Trial of SL-172154
25 May 2023 //
GLOBENEWSWIRE
Shattuck Labs Reports1Q 2023 FYR and Recent Business Highlights
09 May 2023 //
GLOBENEWSWIRE
Shattuck Announces Participation in 22nd Annual Needham Healthcare Conference
03 Apr 2023 //
GLOBENEWSWIRE
Shattuck Labs Presents Preclinical Data at the 2023 AACR Meeting
16 Mar 2023 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming March Conferences
01 Mar 2023 //
GLOBENEWSWIRE
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Shattuck to Report Fourth-Quarter and Full-Year 2022 Financial Results
16 Feb 2023 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming SVB Securities Conference
09 Feb 2023 //
GLOBENEWSWIRE
Shattuck Labs Provides Corporate Update and Highlights Key Milestones in 2023
09 Jan 2023 //
GLOBENEWSWIRE
Shattuck Labs Reports3Q 2022 Financial Results and Recent Business Highlights
08 Nov 2022 //
GLOBENEWSWIRE
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engage
07 Nov 2022 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming November Conferences
03 Nov 2022 //
GLOBENEWSWIRE
Shattuck Labs to Report 3Q 2022 FYR on November 8, 2022
01 Nov 2022 //
GLOBENEWSWIRE
Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager
05 Oct 2022 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming September Conferences
01 Sep 2022 //
GLOBENEWSWIRE
Shattuck Labs Reports Q2 2022 Rusult and Recent Business Highlights
11 Aug 2022 //
GLOBENEWSWIRE
Shattuck Labs Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Shattuck Labs Presents Preclinical Data at the 2022 AACR
08 Apr 2022 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Needham Healthcare Conference
05 Apr 2022 //
GLOBENEWSWIRE
Shattuck Labs Reports Q4 and FY 2021 Financial Results
15 Mar 2022 //
GLOBENEWSWIRE
Shattuck Labs to Present Two Posters at the 2022 AACR
09 Mar 2022 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in Upcoming March Conferences
02 Mar 2022 //
GLOBENEWSWIRE
Shattuck Labs to Participate in Upcoming 11th Annual SVB Leerink Conference
09 Feb 2022 //
GLOBENEWSWIRE
Shattuck Labs Announces Changes to its Board of Directors
28 Oct 2021 //
GLOBENEWSWIRE
Shattuck Labs to Present Clinical Data on SL-172154
01 Oct 2021 //
GLOBENEWSWIRE
Shattuck Labs Announces Participation in the BTIG Biotechnology Conference
06 Aug 2021 //
GLOBENEWSWIRE
Shattuck Labs to Report Second Quarter 2021 Financial Results
04 Aug 2021 //
GLOBENEWSWIRE
Shattuck Labs Highlights Preclinical Data for SL-9258 (TIGIT-Fc-LIGHT)
13 Apr 2021 //
GLOBNEWSWIRE
Shattuck Labs Announces Pricing of Upsized Initial Public Offering
08 Oct 2020 //
BUSINESSWIRE
Oncology biotech Shattuck Labs files for a $100 million IPO
18 Sep 2020 //
NASDAQ
Shattuck Labs Announces Initiation of Phase 1 Clinical Trial for Ovarian Cancer
31 Aug 2020 //
SHATTUCK LABS
